# Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke

> **NCT04123067** · PHASE1,PHASE2 · TERMINATED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Stroke, Acute
- Hyperglycemia
- Diabetes

## Interventions

- **DRUG:** Pioglitazone 45 mg
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04123067
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-04-07
- **Final completion:** 2021-04-07
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Temporarily suspended due to Pandemic.
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04123067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04123067, "Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04123067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*